AigentBio Logo
Agentic pipelines for biological discovery

Pioneering AI-Driven Biomedical Research

AigentBio is building the future of biomedical research — an agentic platform where AI agents dynamically assemble workflows to handle everything from literature surveys and data analysis to hypothesis testing and automated discovery cycles.

Current status
Community-driven development
Building a global ecosystem of AI agents for biomedical research.
Mission
  • Accelerate biomedical research through AI agents
  • Make data analysis accessible to all researchers
  • Enable automated discovery cycles

Our AI Agent Platform

  • Dynamically assembles workflows based on research queries
  • Performs literature surveys, reasoning, and analysis
  • Handles computational and statistical analysis automatically
  • Generates reports and tests hypotheses autonomously
  • Initiates new research cycles based on results
Our Vision

Community-Driven AI Agent Ecosystem for Biomedical Discovery

In the near future, most routine biomedical data analysis and reasoning will be performed by AI agents. AigentBio is pioneering this transformation by building and engaging a community to create thousands of specialized AI agents that can handle biomedical data of various forms — literature, omics, clinical, and imaging data — with advanced causal inference and automated reasoning capabilities.

Multi-Modal Data Expertise

Thousands of specialized AI agents handling diverse biomedical data types — literature analysis, omics data (genomics, proteomics, metabolomics), clinical records, and medical imaging with domain-specific expertise.

Causal Inference & Reasoning

Advanced AI agents capable of causal inference, automated reasoning, and hypothesis generation to uncover meaningful relationships and insights from complex biomedical datasets.

Community-Driven Platform

Building and engaging a global community of researchers and developers to collaboratively create, share, and improve AI agents, creating an ever-expanding ecosystem of biomedical expertise.

"We believe a community-driven ecosystem of thousands of AI agents will transform biomedical research, making sophisticated multi-modal analysis, causal inference, and automated reasoning accessible to researchers worldwide."

About the project

AigentBio is an engineering effort to make advanced bioinformatics workflows easier to run, easier to audit, and easier to extend. The goal is not a black box — it's a system where every intermediate file and decision is inspectable.

We're starting with single‑cell RNA‑seq because it's one of the highest‑impact and highest‑complexity pipelines in translational research.

Use cases
  • Compare case vs control cell type composition shifts
  • Cluster‑wise differential expression summaries
  • Preranked pathway enrichment (GO:BP / KEGG / Reactome)
  • Generate clear reports for scientific review

Early Demo Available

We have developed an early demonstration of our multi-agent platform showcasing AI-driven biomedical research capabilities.

To experience the future of biomedical research with AI agents, please contact us for a personalized demo.

Request Demo
We'll schedule a walkthrough tailored to your research interests

Multi-Agent Architecture

AigentBio is designed as a decentralized multi-agent ecosystem where thousands of specialized AI agents collaborate to handle diverse biomedical research tasks. Each agent brings domain-specific expertise, from literature analysis and data processing to causal inference and hypothesis generation.

The platform dynamically assembles optimal agent teams based on research requirements, enabling comprehensive analysis across multiple data modalities and research questions through intelligent agent coordination.

Ecosystem Design
  • Specialized agents for different biomedical domains
  • Dynamic agent team formation based on research needs
  • Inter-agent communication and knowledge sharing
  • Community-driven agent development and improvement

Roadmap

Near term
  • Public demo dataset
  • Hosted compute backend
  • Report export
Mid term
  • More workflows (bulk RNA-seq, proteomics)
  • Team workspaces + permissions
  • Cost controls + caching
Long term
  • Plugin ecosystem
  • Model-assisted experiment design
  • Regulatory-grade provenance